Hologic (HOLX) Buys Endomag to Boost Breast Cancer Solutions

Hologic, Inc. (HOLX) announced that it has completed the previously announced acquisition of Endomagnetics Limited (Endomag), a UK-based developer of breast cancer surgery technologies, for approximately $310 million. This strategic move aims to bolster Hologic's breast surgery portfolio, offering surgeons and radiologists an expanded range of innovative solutions for breast cancer procedures. The acquisition reflects Hologic's commitment to advancing women's health and improving patient outcomes through cu ...